Visit the ACCC COVID-19 Resource Center & Discussion Group for Insights on Providing Optimal Patient Care During the Pandemic.
 

Share

    


In This Section

Home / Archived Webinar Details

Clinical Trials Amid COVID-19

Guest: ACCC President Randall A. Oyer, MD
Medical Director, Oncology Program
Penn Medicine Lancaster General Health  

The coronavirus (COVID-19) impacts all facets of healthcare, including the administration of—and patient access to—clinical trials. COVID-19 poses a particularly significant challenge for oncology clinical trials, as investigational approaches are often considered standard of care for many disease types. 

In this webcast, ACCC President Randall A. Oyer, MD, discusses the landscape of oncology clinical trials during the COVID-19 pandemic. Topics include: 

  • The current landscape of clinical trial administration 
  • The FDA’s Guidance on Conduct of Clinical Trials during COVID-19 Pandemic  
  • The practicality of transferring patients to other sites with active trials 
  • A possible shift in focus from prevention/registry trials to treatment trials 
  • How to deal with missing or delayed data
  • Patient hesitancy to enroll in clinical trials
  • Your questions. 

View On-Demand Replay Download Slides